This document provides guidance on the clinical evaluation of medicinal products in the treatment of osteoarthritis.
Keywords: Osteoarthritis, symptom modifying drugs, structure modifying drugs, non-steroidal anti-inflammatory drugs (NSAIDs), clinical development